Connection
Co-Authors
This is a "connection" page, showing publications co-authored by Brian Tooker and Lee Newman.
|
|
Connection Strength |
|
 |
|
 |
|
1.873 |
|
|
|
-
Tooker BC, Ozawa K, Newman LS. CpG promoter methylation status is not a prognostic indicator of gene expression in beryllium challenge. J Immunotoxicol. 2016 05; 13(3):417-27.
Score: 0.641
-
Tooker BC, Brindley SM, Chiarappa-Zucca ML, Turteltaub KW, Newman LS. Accelerator mass spectrometry detection of beryllium ions in the antigen processing and presentation pathway. J Immunotoxicol. 2015 Apr-Jun; 12(2):181-7.
Score: 0.577
-
Tooker BC, Bowler RP, Orcutt JM, Maier LA, Christensen HM, Newman LS. SELDI-TOF derived serum biomarkers failed to differentiate between patients with beryllium sensitisation and patients with chronic beryllium disease. Occup Environ Med. 2011 Oct; 68(10):759-64.
Score: 0.457
-
Tooker BC, Newman LS, Bowler RP, Karjalainen A, Oksa P, Vainio H, Pukkala E, Brandt-Rauf PW. Proteomic detection of cancer in asbestosis patients using SELDI-TOF discovered serum protein biomarkers. Biomarkers. 2011 Mar; 16(2):181-91.
Score: 0.114
-
Sawyer RT, Fontenot AP, Barnes TA, Parsons CE, Tooker BC, Maier LA, Gillespie MM, Gottschall EB, Silveira L, Hagman J, Newman LS. Beryllium-induced TNF-alpha production is transcription-dependent in chronic beryllium disease. Am J Respir Cell Mol Biol. 2007 Feb; 36(2):191-200.
Score: 0.084
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|